Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 4 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

33%

1 of 3 completed trials have results

Key Signals

1 with results

Enrollment Performance

Analytics

No phase data available

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (4)

Showing 4 of 4 trials
NCT04638920Completed

Molecular Breath Print of COPD Patients With Exacerbations Despite Triple Inhalational Therapy

Role: lead

NCT03819361Active Not Recruiting

Effect of Longitudinal Sleep Monitoring on Diagnosis and Treatment Decision in Patients with Suspected Obstructive Sleep Apnea

Role: lead

NCT04638933Completed

Effect of CPAP Therapy on Molecular Breath Patterns in Patients With OSA

Role: lead

NCT04156789Completed

Obstructive Sleep Apnoea in Sarcoidosis

Role: lead

All 4 trials loaded